List view / Grid view
11 June 2018 | By PerkinElmer
For lead optimisation, target-based assays are still the most affordable means of rapidly performing fast iterations and remain core to screening. However, the desire for biological relevance is driving ongoing growth in cell-based assays.
11 June 2018 | By Jeff McMillan (Senior Product Manager Imaging at Molecular Devices)
The global high-content screening (HCS) software and services market accounted for over $500 million in 2017 and is expected to reach approximately $1.4 billion by 2026, increasing at a compound annual growth rate of more than 11%, says Jeff McMillan, Senior Product Manager Imaging, Molecular Devices.
7 June 2018 | By Drug Target Review
A novel PET imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease...
6 June 2018 | By PerkinElmer
High-content assays using 3D objects, such as cysts or organoids, can be challenging from the perspectives of both image acquisition and image analysis.
6 June 2018 | By Sesha Tekur (Key Accounts Manage/Field Application Specialist at Thermo Fisher Scientific)
For the next generation of cell biologists, 3D cell culture and analysis has opened doors to taking applied research one step further.
5 June 2018 | By Thermo Fisher Scientfic
Introducing the Thermo Scientific™ CellInsight™ CX7 LZR High Content Analysis System: the only imaging and analysis platform for advanced performance in screening and analysis.
5 June 2018 | By Drug Target Review
Researchers have developed a new form of microscopy that allows them to observe the formation and evolution of cell membrane focal adhesions…
1 June 2018 | By Drug Target Review
In this issue the latest applications of molecular imaging in drug development are reviewed by Ben Burke and Steve Archibald and new horizons in 3D microscopy are explored by Dimitri Scholz and Karl Gaff.
31 May 2018 | By Drug Target Review
In this issue: the positive impact of genomics on drug discovery, development and deployment, the confluence of biology and technology, and Artificial Intelligence: harnessing the potential to drive progress in drug discovery promises much for phenotypic drug discovery
29 May 2018 | By PerkinElmer
How to perform successful long term live cell imaging in a high-content analysis system.
17 May 2018 | By Dr Zara Kassam (Drug Target Review)
The NIH is supporting efforts to broaden biomedical scientists’ access to cryo-electron microscopy the imaging method that is revolutionising structural biology...
27 April 2018 | By Drug Target Review
A team of researchers led by the University of Missouri has employed a mouse model exhibiting diabetic retinopathy symptoms that could lead to future translational research studies.
24 April 2018 | By Drug Target Review
Researchers have explained the basic science behind multicolour probes that enable targeting of cancer-relevant fructose transporter, delving into the image-based detection of cancer cells...
16 April 2018 | By Dr Zara Kassam (Drug Target Review)
A test of contrast-enhanced subharmonic imaging has shown promise in detecting prostate cancers that were not identified by MRI...
5 April 2018 | By Dr Zara Kassam (Drug Target Review)
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various neurological diseases...
Send this to a friend
Follow: